Refractory primary intestinal lymphangiectasia effectively managed with subcutaneous octreotide.
BMJ Case Rep
; 14(4)2021 Apr 09.
Article
in En
| MEDLINE
| ID: mdl-33837021
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Octreotide
/
Lymphangiectasis, Intestinal
/
Lymphedema
Type of study:
Diagnostic_studies
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
BMJ Case Rep
Year:
2021
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom